Lower Risk of Hepatocellular Carcinoma With Tenofovir vs Entecavir in Patients With Chronic Hepatitis B.

Mei‐Hsuan Lee, Hwai‐I Yang, Jessica Liu, Richard Batrla‐Utermann, Chin‐Lan Jen, Uchenna H Iloeje, Sheng‐Nan Lu, San‐Lin You, Li‐Yu Wang, Chien‐Jen Chen, REVEAL‐HBV Study Group, None, Prediction models of long-term cirrhosis and hepatocellular carcinoma risk in chronic hepatitis B patients: risk scores integrating host and virus profiles. Hepatology. ,vol. 58, pp. 546- 554 ,(2013) , 10.1002/HEP.26385

Yang Yang, Qi-Jun Wu, Li Xie, Wong-Ho Chow, Nat Rothman, Hong-Lan Li, Yu-Tang Gao, Wei Zheng, Xiao-Ou Shu, Yong-Bing Xiang, Prospective cohort studies of association between family history of liver cancer and risk of liver cancer International Journal of Cancer. ,vol. 135, pp. 1605- 1614 ,(2014) , 10.1002/IJC.28792

Rui-Dong Li, Yan-Hua Tang, Hui-Li Wang, Dong Yang, Li-Jun Sun, Wei Li, The SMYD3 VNTR 3/3 polymorphism confers an increased risk and poor prognosis of hepatocellular carcinoma in a Chinese population Pathology - Research and Practice. ,vol. 214, pp. 625- 630 ,(2018) , 10.1016/J.PRP.2018.04.005

Jonggi Choi, Hyo Jeong Kim, Jayoun Lee, Songhee Cho, Min Jung Ko, Young-Suk Lim, Risk of Hepatocellular Carcinoma in Patients Treated With Entecavir vs Tenofovir for Chronic Hepatitis B: A Korean Nationwide Cohort Study. JAMA Oncology. ,vol. 5, pp. 30- 36 ,(2019) , 10.1001/JAMAONCOL.2018.4070